M&T Bank
MTB
$217.49
-0.03%
M&T Bank Corporation is a US regional bank holding company headquartered in Buffalo, New York, operating over 900 branches across 13 states and Washington, D.C., with roughly $220 billion in assets as of mid-2026. Its core business spans commercial and retail banking, complemented by wealth management through Wilmington Trust and a corporate trust franchise, giving it a diversified but regionally concentrated footprint in New England and the Mid-Atlantic. The bank is distinct as a conservatively run, community-banking-oriented lender with a long-standing reputation for disciplined credit underwriting and a loyal deposit base, rather than a capital-markets-driven or technology-first disruptor. The current investor narrative centers on net interest margin resilience in a rate environment where funding costs have pressured regional bank profitability, alongside a notable Q2 2026 earnings rebound (EPS of $5.23 versus $4.24 in Q1) that has reignited debate over whether the sector's margin trough has passed. Attention is also focused on the stock's underperformance relative to the broader market, with shares lagging SPY over the past three and six months, prompting questions about whether valuation support and a 3.3% dividend yield offer sufficient compensation for the growth gap.…
MTB
M&T Bank
$217.49
Related headlines
Investment Opinion: Should I buy MTB Today?
The synthesized recommendation is Hold, reflecting a balanced view of MTB's deep value valuation and improving earnings against its persistent underperformance and tepid growth. The analyst consensus rating of 'hold' (mean 2.7) and average target price of $254.86 imply a 16.3% upside, but this is offset by the stock's 8.26% decline over the past three months and a 13.1% relative underperformance versus SPY over six months. The core thesis is that MTB is a well-capitalized, conservatively managed regional bank trading at a discount, but lacks a clear catalyst to close the valuation gap in the near term.
Supporting evidence for the Hold rating includes the attractive valuation at 1.08x book value and 10.4x forward earnings, which is below the broader market and historical averages. The Q2 2026 EPS of $5.23 represents a 23.3% sequential increase and a 23.4% year-over-year rise from $4.24, signaling potential margin stabilization. The dividend yield of 3.31% with a conservative 36.7% payout ratio and $3.68 billion in trailing free cash flow provides income and downside support. Additionally, the low beta of 0.563 offers defensive characteristics, and the average analyst target of $254.86 suggests that sell-side analysts see value at current levels.
The biggest risks that could invalidate the thesis include a reversal in net interest margin expansion, a deterioration in credit quality, and continued relative underperformance that could lead to further multiple compression. This Hold would upgrade to Buy if the stock breaks above $240 with sustained volume and revenue growth accelerates above 5%, or if the forward PE compresses below 9x while earnings estimates remain stable. Conversely, it would downgrade to Sell if revenue growth turns negative, the dividend payout ratio exceeds 50%, or the stock breaks below the 52-week low of $174.76. Relative to its history and peers, MTB appears undervalued on a price-to-book basis, but the market is pricing in structural challenges that may take several quarters to resolve.
Sign up to view all
MTB 12-Month Price Forecast
MTB presents a mixed picture: the Q2 earnings rebound and deep value valuation are compelling, but the stock's persistent underperformance and anemic revenue growth suggest structural challenges. The low beta and high dividend yield offer defensive appeal, yet the high short interest and 'hold' consensus indicate limited near-term catalysts. I would upgrade to bullish if revenue growth accelerates above 4% and net interest margin expands for two consecutive quarters, and downgrade to bearish if credit quality deteriorates or the dividend payout ratio exceeds 50%. The risk/reward is balanced, with the base case (55% probability) targeting $240-270 over 12 months.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on M&T Bank's 12-month outlook, with a consensus price target around $251.78 and implied upside of +15.8% versus the current price.
Average Target
$251.78
0 analysts
Implied Upside
+15.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$224 - $301
Analyst target range
Bulls vs Bears: MTB Investment Factors
The bear case currently has stronger evidence, primarily due to MTB's persistent underperformance versus the S&P 500 across all timeframes and its anemic 2.07% revenue growth. However, the bull case is gaining traction following the sharp Q2 earnings rebound and deeply discounted valuation at 1.08x book value. The most critical tension is whether the Q2 EPS surge to $5.23 represents a sustainable inflection in net interest margin or merely a one-quarter anomaly. If margins continue to expand, the stock could re-rate toward analyst targets; if the rebound fades, the underperformance may persist.
Bullish
- Earnings rebound signals margin trough: Q2 2026 EPS surged to $5.23 from $4.24 in Q1 2026, a 23.3% sequential increase, while net income rose to $818 million from $664 million. This sharp rebound suggests the net interest margin compression that pressured regional banks may have finally reversed.
- Deep value valuation with 1.08x P/B: MTB trades at just 1.08x book value and 11.85x trailing earnings, well below the broader market and historical regional bank averages. The forward PE of 10.4x implies the market is pricing in minimal growth despite the recent earnings acceleration.
- Attractive dividend yield and payout safety: The stock offers a 3.31% dividend yield with a conservative 36.7% payout ratio, supported by $3.68 billion in trailing free cash flow. This provides a steady income stream and downside cushion for value-oriented investors.
- Analyst targets imply 16% upside: The average analyst price target of $254.86 represents a 16.3% premium to the current price of $219.14, with a high target of $301.00. Even the low target of $224.00 is slightly above the current price, suggesting limited downside according to sell-side estimates.
Bearish
- Significant underperformance versus SPY: MTB has lagged the S&P 500 across all key timeframes, with a 3-month relative strength of -11.6% and 6-month relative strength of -13.1%. The stock is down 8.26% over three months while SPY gained 3.34%, highlighting persistent weakness.
- Revenue growth barely positive: Q2 2026 revenue grew only 2.07% year-over-year to $3.36 billion, a tepid pace that lags inflation and broader economic growth. This anemic top-line expansion limits the bank's ability to generate meaningful earnings leverage.
- High short interest signals skepticism: The short ratio of 5.14 indicates that it would take over five days of average trading volume to cover all short positions, reflecting meaningful bearish sentiment. This elevated short interest could amplify downside moves if negative news emerges.
- Hold consensus with limited conviction: The analyst consensus rating is 'hold' with a recommendation mean of 2.7 out of 5, indicating mixed views. With 18 analysts covering the stock, the lack of a stronger buy consensus suggests limited near-term catalysts to drive outperformance.
MTB Technical Analysis
Beta
0.61
0.61x market volatility
Max Drawdown
-17.6%
Largest decline past year
52-Week Range
$175-$256
Price range past year
Annual Return
+15.7%
Cumulative gain past year
| Period | MTB Return | S&P 500 |
|---|---|---|
| 1m | -8.6% | +2.1% |
| 3m | -10.3% | +3.1% |
| 6m | -1.1% | +14.6% |
| 1y | +15.7% | +16.0% |
| ytd | +6.6% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MTB Fundamental Analysis
Quarterly Revenue
$3.4B
2026-06
Revenue YoY Growth
+2.1%
YoY Comparison
Gross Margin
71.8%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MTB Overvalued?
PE
11.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.2x
Enterprise Value Multiple
Investment Risk Disclosure
M&T Bank faces financial risks stemming from its regional banking model, including a debt-to-equity ratio of 0.45 and a current ratio of just 0.32, which reflects the inherently leveraged nature of bank balance sheets. While the bank maintains a net margin of 23.2% and ROE of 9.77%, these profitability metrics remain below pre-pandemic levels and could compress further if funding costs rise. The bank's revenue concentration in net interest income makes it highly sensitive to rate changes, and its 2.07% year-over-year revenue growth offers little buffer against margin pressure. Additionally, the payout ratio of 36.7% and dividend yield of 3.31% require sustained earnings to remain secure, and any deterioration in credit quality could threaten both the dividend and capital adequacy.
Market and competitive risks are significant given MTB's underperformance relative to peers and the broader market, with a 6-month relative strength of -13.1% versus SPY. The stock's low beta of 0.563 reduces market correlation but also means it may lag in strong bull markets, as evidenced by its 12.0% 1-year return versus SPY's 15.0%. The regional banking sector faces structural challenges from fintech disruption, regulatory capital requirements, and potential deposit competition from larger money-center banks. Recent news of a maintained $1.50 quarterly dividend provides some stability, but the lack of positive catalysts and a 'hold' consensus rating suggest limited near-term upside. Sector rotation away from financials could further pressure the stock if investors favor growth sectors.
In a worst-case scenario, a deterioration in credit quality or a sharp economic downturn could trigger a re-rating toward the 52-week low of $174.76, representing a 20.3% decline from the current price of $219.14. If net interest margins compress again and loan loss provisions rise, the stock could fall below the analyst low target of $224.00 and test the 52-week low. A more severe scenario involving a regional banking crisis or significant deposit outflows could push the stock toward its historical max drawdown of -17.55%, implying a price near $180.70. Investors could lose 20-25% from current levels in such an adverse scenario, with the downside amplified by the high short interest (short ratio of 5.14) that could accelerate selling pressure.
FAQ
The most severe risk is credit deterioration in a recession, which could lead to higher loan loss provisions and erode profitability, potentially pushing the stock toward its 52-week low of $174.76. Second, net interest margin compression remains a threat if deposit costs rise faster than loan yields, as evidenced by the 2.07% revenue growth in Q2 2026. Third, regulatory risks could increase capital requirements, limiting the bank's ability to return capital to shareholders. Fourth, competitive pressures from fintech and larger banks could lead to deposit outflows and market share loss. Finally, the high short interest (short ratio of 5.14) amplifies downside volatility if negative news emerges.
Our 12-month forecast for MTB includes three scenarios: a bull case (25% probability) targeting $280-301, driven by sustained margin expansion and EPS growth toward $23.86; a base case (55% probability) targeting $240-270, assuming steady but unspectacular performance with EPS around $23.28; and a bear case (20% probability) targeting $174.76-224, triggered by recession-induced credit deterioration. The base case is most likely, with the stock trading around the analyst average target of $254.86. The key assumption is that net interest margin stabilizes and revenue growth remains positive but modest. Investors should monitor quarterly earnings for signs of acceleration or deterioration.
MTB appears undervalued on a price-to-book basis, trading at 1.08x book value compared to the broader regional bank average of 1.2-1.5x. The trailing PE of 11.85 and forward PE of 10.4 are also below the S&P 500's average, suggesting the market is pricing in minimal growth. However, the PEG ratio of 0.76 indicates that the valuation is reasonable relative to expected earnings growth. The dividend yield of 3.31% is above the sector median, providing additional value. Overall, the market seems to be pricing in structural challenges for regional banks, but if earnings momentum continues, the stock could re-rate higher toward its historical average of 1.3x book value.
MTB could be a good buy for value-oriented investors seeking income and low volatility, given its 3.31% dividend yield, 1.08x price-to-book ratio, and 16.3% upside to the average analyst target of $254.86. However, the stock has underperformed the S&P 500 by 13.1% over six months and revenue growth is only 2.07% year-over-year, suggesting limited near-term catalysts. The high short ratio of 5.14 indicates bearish sentiment that could pressure the stock further. For patient investors with a 12-18 month horizon, the risk/reward is balanced, but those seeking growth or momentum should look elsewhere. A good entry point might be near the 52-week low of $174.76, which would offer a more attractive margin of safety.
MTB is more suitable for long-term investment, given its low beta of 0.563, stable dividend yield of 3.31%, and deep value valuation that may take several quarters to fully realize. Short-term trading is less attractive due to the stock's recent underperformance and lack of near-term catalysts, with a 3-month relative strength of -11.6% versus SPY. The high short interest and 'hold' consensus suggest that a quick re-rating is unlikely. A minimum holding period of 12-18 months is recommended to allow for potential margin recovery and multiple expansion. Income-focused investors may find the dividend appealing for longer horizons, while growth-oriented traders should look for a breakout above $240 before considering entry.